Disease Detection news and technical articles from BioOptics World. Search Disease Detection latest and archived news and articles
An optofluidic laser in development at the University of Texas at Arlington (UTA) promises better disease detection —including cancer—in a clinician's office, and has been awarded a National Science Foundation (NSF; Arlington, VA) five
have launched the CARDIS project, which will involve developing and validating an early-stage cardiovascular disease detection platform using integrated silicon photonics . The project's main goal is the investigation and demonstration of
sensitive biosensor capable of identifying the smallest single virus particles in solution, which could advance early disease detection at the point-of-care and cut waiting for test results from weeks to minutes.
NanoSight (Amesbury, England) to quickly size and phenotype cellular vesicles for use as biomarkers for early disease detection . Their findings overcome previous limitations in the technology available for their measurement. The NTA system
Single-molecule technologies are now allowing measurement of proteins at subfemtomolar concentrations. The advance has enabled the development of assays to detect various cancers and neurological conditions at their very earliest stages.
Fiber-optic microscopy is promising for very early cancer detection, surgical guidance, and as a complement to standard pathology.
A biosensor able to identify the smallest single virus particles (each just 6 attograms) hopes to revolutionize early disease diagnosis by providing results within minutes at the point of care.
biomarkers need to be present compared to a conventional immunoassay. The development opens new opportunities for early disease detection and treatment—and perhaps equally important, it requires no changes for researchers and technicians: The new procedure
A fiber laser able to produce 25 times more light than other lasers operating at a similar wavelength has proven able to detect very low concentrations of gases.
Recent advances in optics and electronics could make cytometric technology highly affordable and broadly applicable within the next few years, filling new niches and challenging the traditional dominance of flow cytometry in some older ones.